81 results on '"B.E. Johnson"'
Search Results
2. NAUTIKA1: A Multicenter Phase II Study with a PD-L1+ Cohort of Patients Receiving Atezolizumab (Atezo) with Low-Dose Stereotactic Body Radiation Therapy (SBRT) as Neoadjuvant Therapy for Resectable Stage IB-III NSCLC
- Author
-
S. Tian, D.E. Kozono, N. Ohri, S. Jolly, B.E. Johnson, J. Chaft, E.M. Toloza, B. Ding, C. Ngiam, K. Schulz, I. Bara, and J.M. Lee
- Subjects
Cancer Research ,Radiation ,Oncology ,Radiology, Nuclear Medicine and imaging - Published
- 2022
3. EP02.04-005 Phase II NAUTIKA1 Study of Targeted Therapies in Stage II-III NSCLC: Preliminary Data of Neoadjuvant Alectinib for ALK+ NSCLC
- Author
-
J.M. Lee, B. Sepesi, E.M. Toloza, J. Lin, H.I. Pass, B.E. Johnson, J.V. Heymach, M.L. Johnson, B. Ding, K. Schulze, Q. Zhu, C. Ngiam, E. Brandão, I. Bara, and J. Chaft
- Subjects
Pulmonary and Respiratory Medicine ,Oncology - Published
- 2022
4. OA14.06 T-Cell Dynamics in Response to Neoadjuvant Atezolizumab in Early NSCLC by Antigen Response and T-Cell Receptor Sequencing
- Author
-
F. Oezkan, S. Hilz, J. Grindheim, A. Wallace, M. Seweryn, A. Reuben, J. Zhang, D.H. Owen, A. Nicholas, M. Yadav, D. Nagarkar, P. de Almeida, P. Ebert, E. Osborne, A. Johnson, J.M. Lee, P. Bunn, B.E. Johnson, J. Chaft, M.G. Kris, V.W. Rusch, K. Schulze, D.J. Kwiatkowski, I.I. Wistuba, and D.P. Carbone
- Subjects
Pulmonary and Respiratory Medicine ,Oncology - Published
- 2022
5. 1O Dynamic circulating tumour DNA (ctDNA) response to neoadjuvant (NA) atezolizumab (atezo) and surgery (surg) and association with outcomes in patients (pts) with NSCLC
- Author
-
M.G. Kris, J.M. Grindheim, J.E. Chaft, J.M. Lee, B.E. Johnson, V.W. Rusch, P.A. Bunn, H. Pass, E. Schum, J. Carlisle, M. Weyant, A. Nicholas, A. Johnson, D. Shames, I.I. Wistuba, D.P. Carbone, K. Schulze, and D.J. Kwiatkowski
- Subjects
Oncology ,Hematology - Published
- 2021
6. New targets and new treatments in non-small cell lung cancer
- Author
-
B.E. Johnson
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,Bevacizumab ,biology ,business.industry ,Combination chemotherapy ,medicine.disease ,Gemcitabine ,Carboplatin ,chemistry.chemical_compound ,Gefitinib ,chemistry ,Internal medicine ,Immunology ,Adenocarcinoma of the lung ,medicine ,biology.protein ,Epidermal growth factor receptor ,business ,Lung cancer ,medicine.drug - Abstract
New agents directed against molecular targets have now been tested in large prospectively randomized clinical trials for patients with untreated advanced non-small cell lung cancer (NSCLC). The trials have included small molecule inhibitors of receptor tyrosine kinases (gefitinib and erlontinib), monoclonal antibodies directed against either the ligands (bevicizumab against vascular endothelial growth factor) or their receptors (trastuzumab against ErbB2) and antisense nucleotides directed against mRNA coding for molecular targets (ISIS 3521 against protein kinase C alpha). The largest mature trials have included agents directed against ErbB1 (epidermal growth factor receptor). Two different small molecule inhibitors of erbB1 (gefitinib and erlontinib) and have been tested in 4 large international randomized trials. Two trials treated patients with advanced NSCLC with either gemcitabine and cisplatin or the same chemotherapy drugs combined with two different doses of gefitinib or one dose of erlontinib (INTACT 1 and TALENT). The other two trials treated patients with advanced NSCLC with either paclitaxel and carboplatin or the same chemotherapy drugs combined with either one of two doses of gefitinib or a single dose of erlontinib (INTACT 2 or TRIBUTE respectively). The results of INTACT 1 and INTACT2 showed no significant difference in survival between those treated with conventional combination chemotherapy and those treated with the same chemotherapy plus gefitinib. The results of the TRIBUTE and TALENT studies showed their primary endpoints of improving overall survival were not met. The monoclonal antibody, bevacizumab, is being tested in an ongoing clinical trial. The trial will compare the outcome of patients with untreated advanced adenocarcinoma of the lung treated with paclitaxel plus carboplatin to those treated with the same chemotherapy drugs plus bevacizumab. The results are scheduled to be available in 2005–2006. Although the initial trials adding newly developed molecular targeted agents have not shown initial success when added to conventional combination chemotherapy, further clinical trials are needed to ultimately define their role in the treatment of non-small cell lung cancer.
- Published
- 2004
7. As good as it gets: optimal fab design and deployment
- Author
-
D.L. Benavides, J.R. Duley, and B.E. Johnson
- Subjects
Engineering ,Operations research ,business.industry ,Scale (chemistry) ,Inversion (meteorology) ,Condensed Matter Physics ,Investment (macroeconomics) ,Industrial and Manufacturing Engineering ,Electronic, Optical and Magnetic Materials ,Economies of scale ,Production planning ,Software deployment ,Factory (object-oriented programming) ,Electronics ,Electrical and Electronic Engineering ,business - Abstract
This paper presents and applies a methodology for determining the optimal scale, type, and timing of IC manufacturing capacity additions when demand is uncertain. Using the methodology, six different 200-mm fab designs are evaluated, including standard 10 K- and 20 K-wafer start per month (ws/mo) facilities, a 5 K-ws/mo "minifab," and "sequentially deployable" or "expandable" 10 K- and 20 K-ws/mo facilities. The results suggest that in the presence of uncertainty, manufacturers should follow a conservative deployment policy (better late than early to avoid periods of costly underutilization). In addition, when optimally deployed, larger, more efficient facilities are economically more viable than smaller fabs, since they are capable of generating substantially larger profits with comparable risks of loss, Sequentially deployable large fabs are even more attractive since they offer the economies of scale of larger fabs but require a smaller initial capital outlay.
- Published
- 1999
8. Use of spin-polarized electron-energy-loss spectroscopy to investigate dipole and impact scattering from transition-metal surfaces
- Author
-
H. Hsu, F. B. Dunning, B.E. Johnson, G. K. Walters, and M. Magugumela
- Subjects
Physics ,Dipole ,Scattering ,Electron energy loss spectroscopy ,Electron ,Inelastic scattering ,Atomic physics ,Mott scattering ,Polarization (waves) ,Electron spectroscopy - Abstract
Spin polarized electron-energy-loss spectra have been obtained from Ag(100), Cu(100), Mo(110) and unmagnetized Co(110) and Fe(100) surfaces, in both specular and off-specular scattering geometries, by use of a low-energy polarized incident beam coupled with energy- and angle-resolved spin analysis of the scattered electrons. The data are interpreted in terms of a model that takes account of both dipole and impact scattering. Dipole scattering preserves the full polarization of the incident beam, whereas the scattered electron polarization is degraded by electron exchange in impact-scattering events that produce electron-hole pair excitation in the target. It is found that dipole scattering dominates at noble-metal surfaces but that the impact- and dipole-scattering rates are comparable for targets with incompletely filled d shells. The data also suggest that impact scattering, like dipole scattering, tends to be concentrated in the specular direction. {copyright} {ital 1997} {ital The American Physical Society}
- Published
- 1997
9. Evidence that certain phototoxic drugs photosensitize urocanic acid isomerization
- Author
-
B.E. Johnson, Neil K. Gibbs, and Gavin Torr
- Subjects
Doxycycline ,Ketoprofen ,Radiation ,Radiological and Ultrasound Technology ,Photoisomerization ,medicine.medical_treatment ,Biophysics ,Immunosuppression ,Pharmacology ,Photochemistry ,In vitro ,Urocanic acid ,chemistry.chemical_compound ,chemistry ,In vivo ,medicine ,Radiology, Nuclear Medicine and imaging ,Phototoxicity ,medicine.drug - Abstract
Trans to cis photoisomerization of epidermal urocanic acid (UCA) has been proposed as a primary event in UV-induced immunosuppression. 8-Methoxypsoralen (8-MOP) in combination with UVA radiation (PUVA) is used for photochemotherapy of several immunologicaly based skin disorders, and PUVA is known to cause immunosuppression. We examined the photointeraction of 8-MOP and other skin photosensitizing drugs (amiodarone, ciprofloxacin, doxycycline and ketoprofen) with trans-UCA in vitro. In oxic condition 8-MOP did not enhance the ability of radiation from standard PUVA fluorescent sources (0.2% radiation below 320 nm) to produce cis-UCA. When oxygen was removed, some 8-MOP photosensitization could be detected. 8-MOP, ciprofloxacin and ketoprofen also enhanced inefficient UCA photoisomerization by radiation from a filtered tungsten halogen source (0.2% radiation below 320 nm). 8-MOP photosensitization is essential for radiation from PUVA tubes to have a therapeutic or immunosuppressive effect. We have shown in vitro that 8-MOP does not enhance cis-UCA production by this source. Extrapolation of our data to the in vivo situation suggests that UCA may not be involved in either the therapeutic or the immunosuppressive effect of PUVA.
- Published
- 1996
10. The Phototumorigenic Potential of Broad-Band (270–350 nm) and Narrow-Band (311–313 nm) Phototherapy Sources Cannot Be Predicted by Their Edematogenic Potential in Hairless Mouse Skin
- Author
-
N.K. Gibbs, I. Campbell, B.E. Johnson, James Ferguson, N. J. Traynor, and Rona M. MacKie
- Subjects
medicine.medical_specialty ,Neoplasms, Radiation-Induced ,Ultraviolet Rays ,Cumulative Exposure ,Sunburn ,Dermatology ,Biochemistry ,Mice ,Psoriasis ,Edema ,medicine ,Animals ,Molecular Biology ,Skin ,Mice, Hairless ,business.industry ,Incidence ,Dose-Response Relationship, Radiation ,Cell Biology ,medicine.disease ,Hairless ,Dose–response relationship ,Mouse skin ,Female ,medicine.symptom ,Skin cancer ,Nuclear medicine ,business - Abstract
The new Philips TL01 narrow-band (311-313 nm) and conventional broad-band (e.g., Philips TL12; 270-350 nm) sources are effective for psoriasis phototherapy, for which treatment regimens are based on a predetermined minimal erythema dose. TL01 phototherapy treatment times are approximately half those with TL12 for psoriasis, whereas the cumulative exposure doses at clearing are similar. We compared the phototumorigenic potential of TL01 and TL12 radiation in mouse skin. Groups of albino Skh-1 hairless mice were exposed for 5 d/week at three dose levels. At each dose level, TL12 and TL01 doses were equally edematogenic. At each dose level, TL01 radiation was significantly more effective at producing first tumors of 1 mm in diameter and multiple tumors. At the lower two dose levels, TL01 radiation produced a significantly greater proportion of squamous cell carcinomas. This study demonstrates that TL01 radiation is more phototumorigenic than TL12 radiation at equally edematogenically weighted doses. This is in contrast with previous reports that edema production by polychromatic sources is predictive of their phototumorigenic effect in Skh-1 mice. The absolute cumulative TL12 dose needed to induce tumors was much less than that for TL01 radiation. The possibility of increased tumor risk with TL01 phototherapy should be considered but must be balanced against the high phototherapeutic efficacy of this source, short treatment times, and the low cumulative doses necessary for clearing of psoriasis.
- Published
- 1995
- Full Text
- View/download PDF
11. In Vitro Phototoxicity Testing
- Author
-
B.E. Johnson, Horst Spielmann, Orazio Sapora, Thomas Maurer, Erhard Hölzle, Will W. Lovell, Wolfgang Pape, Miguel A. Miranda, and Dariusz Sladowski
- Subjects
Alternative methods ,Chemical compound ,business.industry ,General Medicine ,Pharmacology ,Toxicology ,General Biochemistry, Genetics and Molecular Biology ,In vitro ,Medical Laboratory Technology ,chemistry.chemical_compound ,Investigation methods ,chemistry ,Photosensitivity ,Medicine ,business ,Phototoxicity - Published
- 1994
12. Cellular Sensitivity to Oxidative Stress in the Photosensitivity Dermatitis/Actinic Reticuloid Syndrome
- Author
-
Lee Ann Applegate, B.E. Johnson, James Ferguson, Neil K. Gibbs, Edgar Frenk, and Rex M. Tyrrell
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,Cell Survival ,Ultraviolet Rays ,Photodermatosis ,hydrogen peroxide ,oxidative damage ,Dermatology ,medicine.disease_cause ,Biochemistry ,Ataxia Telangiectasia ,chemistry.chemical_compound ,Photosensitivity ,medicine ,Humans ,Chronic actinic dermatitis ,UVA radiation ,Photosensitivity Disorders ,RNA, Messenger ,Child ,Hydrogen peroxide ,Fibroblast ,Molecular Biology ,Cells, Cultured ,Aged ,Aged, 80 and over ,Dermatitis, Photoallergic ,Syndrome ,Cell Biology ,Fibroblasts ,Middle Aged ,Oxidants ,medicine.disease ,Molecular biology ,Heme oxygenase ,medicine.anatomical_structure ,Gene Expression Regulation ,chemistry ,Child, Preschool ,Heme Oxygenase (Decyclizing) ,Ataxia-telangiectasia ,Female ,Oxidative stress - Abstract
Skin fibroblasts from certain patients with the photosensitivity dermatitis/actinic reticuloid syndrome show enhanced sensitivity to ultraviolet radiation compared to normal fibroblasts. To probe further the link between oxidative damage and this disease, we have obtained a more extensive set of cell lines from patients with a severe form of the disease and examined their sensitivity towards oxidative stress by measuring cell survival following UVA radiation (330-450 nm) or hydrogen peroxide treatment (0.1-2.4 mM). The activation of the stress gene, heme oxygenase, has also been assessed by measuring the accumulation of mRNA after hydrogen peroxide treatment. Our studies have confirmed that a slight ultraviolet sensitivity is a characteristic of photosensitivity dermatitis/actinic reticuloid syndrome cell strains and we further demonstrate that these cell lines are particularly sensitive to hydrogen peroxide with up to a three- to fourfold increased sensitivity as compared to normal controls. We also show that certain ataxia telangiectasia strains that are especially sensitive to hydrogen peroxide are also slightly sensitive to ultraviolet radiation. Hydrogen peroxide induces accumulation of mRNA for the oxidant-inducible stress protein, heme oxygenase, with similar kinetics (maximum mRNA accumulation 2-4 h following treatment) and with a similar range of magnitudes in both normal (6.6-20.6 times mRNA increase over basal levels) and photosensitivity dermatitis/actinic reticuloid (2.9-12.8 times) skin cells. Because cells from photosensitivity dermatitis/actinic reticuloid patients show increased sensitivity towards oxidative stress but show no significant change in oxidant activation of the heme oxygenase gene, we propose that the defect involves a late stage of processing of oxidative damage rather than a compromised free radical scavenging system.
- Published
- 1994
13. A comparison of the efficacy and relapse rates of narrowband UNV (TL-01) monotherapy vs. etretinate (re-TL-01) vs. etretinate-PUVA (re-PUVA) in the treatment of psoriasis patients
- Author
-
B.E. Johnson, C. Green, T. Lakshmipathi, and James Ferguson
- Subjects
Adult ,Male ,medicine.medical_specialty ,Combination therapy ,medicine.medical_treatment ,Etretinate ,Dermatology ,Gastroenterology ,Ultraviolet therapy ,law.invention ,Randomized controlled trial ,Recurrence ,law ,Psoriasis ,Internal medicine ,medicine ,Humans ,PUVA Therapy ,Chemotherapy ,business.industry ,medicine.disease ,Combined Modality Therapy ,Chronic Disease ,PUVA therapy ,Female ,Ultraviolet Therapy ,business ,Guttate psoriasis ,medicine.drug - Abstract
Forty-five patients with extensive chronic plaque or guttate psoriasis were treated with either narrowband (TL-01) phototherapy, etretinate TL-01 combination therapy (re-TL-01) or etretinate and PUVA (re-PUVA) (15 patients in each group). Re-PUVA was the most effective therapy with 100% satisfactory clearance rate. TL-01 monotherapy had an 80% success rate; the relapse rate compared favourably with re-PUVA (50% in remission after 6 months). In the etretinate-TL-01 group, there was a 93% success rate and a one-third reduction in the total irradiation dose (8.0 J/cm2 vs. 12.7 J/cm2) but the relapse rate was higher, only 33% remaining in remission after 6 months.
- Published
- 1992
14. Thermal stability of polysilicon resistors
- Author
-
B. El-Kareh, J.E. Suarez, and B.E. Johnson
- Subjects
Materials science ,Silicon ,Dopant ,Annealing (metallurgy) ,viruses ,Doping ,General Engineering ,chemistry.chemical_element ,Industrial and Manufacturing Engineering ,Electronic, Optical and Magnetic Materials ,chemistry ,Electronic engineering ,Furnace anneal ,Thermal stability ,Electrical and Electronic Engineering ,Composite material ,Boron ,Sheet resistance - Abstract
The stability of polysilicon sheet resistance was studied as a function of conventional furnace anneal (CFA) and rapid thermal anneal (RTA). Polysilicon films of 100, 200, and 300 nm thickness were doped with boron, borofluoride, arsenic, or phosphorus and subjected to a CFA anneal matrix simulating the thermal cycles of a digital base BiCMOS process. RTA was introduced at the beginning or the end of the CFA anneal cycle to study its effectiveness in stabilizing the sheet resistance. CFA temperature was varied from 550 to 900 degrees C, and RTA temperature from 900 to 1100 degrees C. Throughout this range, it was found that the resistance depends primarily on the final anneal temperature and duration. The resistance increases substantially when the samples are subjected to a final low temperature anneal cycle, and decreases dramatically when followed by high temperature RTA. This was observed for arsenic- phosphorus-, and boron-doped films. It is suggested that the duration of cooling plays an important role in determining the nominal film resistance, thus explaining the efficiency of RTA in reducing and stabilizing the resistance. The results are compared with available models on dopant redistribution and carrier transport in polysilicon films. >
- Published
- 1992
15. Ciprofloxacin-induced photosensitivity: in vitro and in vivo studies
- Author
-
James Ferguson and B.E. Johnson
- Subjects
Adult ,Male ,Light ,Nalidixic acid ,Erythema ,Human skin ,Dermatology ,Biology ,Hemolysis ,Microbiology ,Mice ,Nalidixic Acid ,Photosensitivity ,Ciprofloxacin ,In vivo ,Candida albicans ,medicine ,Animals ,Humans ,Histidine ,Lymphocytes ,Photosensitivity Disorders ,Cells, Cultured ,Aged ,Aged, 80 and over ,Photolysis ,Macrophages ,DNA ,Middle Aged ,Molecular biology ,In vitro ,Female ,medicine.symptom ,Phototoxicity ,medicine.drug - Abstract
Ciprofloxacin is one of the new series of broad-spectrum antibiotic quinolones, chemically related to nalidixic acid and which may, therefore, induce photosensitization of human skin. Three in vitro tests for phototoxicity: the destruction of histidine, killing of mouse peritoneal macrophages and inhibition of PHA-stimulated DNA synthesis in human lymphocytes have demonstrated this photosensitizing potential with UVA irradiation at an order of magnitude lower than that for nalidixic acid. The Candida albicans test and photohaemolysis were negative. Controlled irradiation monochromator phototesting of 12 subjects, before, during and after taking ciprofloxacin showed subclinical photosensitivity with significantly lowered minimal 24 h erythema doses at 335 +/- 30 nm, 365 +/- 30 nm and 400 +/- 30 nm but not at 305 +/- 5 nm or above 400 +/- 30 nm.
- Published
- 1990
16. Quinolone antibiotic with potential to photosensitize skin tumorigenesis
- Author
-
B.E. Johnson, N.K. Gibbs, and James Ferguson
- Subjects
Radiation-Sensitizing Agents ,Neoplasms, Radiation-Induced ,Skin Neoplasms ,Radiation ,Radiological and Ultrasound Technology ,Ultraviolet Rays ,business.industry ,Biophysics ,medicine.disease_cause ,Mice ,Fleroxacin ,Anti-Infective Agents ,Quinolone antibiotic ,Cancer research ,Animals ,Medicine ,Radiology, Nuclear Medicine and imaging ,business ,Carcinogenesis ,Dermatitis, Phototoxic - Published
- 1997
17. Optimizing tool availiability and lead time with procurement options
- Author
-
B.E. Johnson
- Subjects
Lead (geology) ,business.product_category ,Procurement ,business.industry ,Financial risk ,Control (management) ,Liability ,Operations management ,Customer relationship management ,business ,Lead time ,Machine tool - Abstract
"Procurement options" provide manufacturers with guaranteed, reduced tool lead times in exchange for the assumption of liability for a portion of the capacity and material costs a tool supplier must incur to support this commitment. Appropriately constructed and managed portfolios of procurement options allow manufacturers to control capacity availability, cost, lead time and liability, making possible predictable operating and financial performance tailored to management's objectives. By managing customer relationships with procurement options, suppliers are similarly able to significantly improve both cost and efficiency of planning and execution, and reduce their operating and financial risk
- Published
- 2005
18. Financial comparison of 200 mm vs. 300 mm IC manufacturing facilities
- Author
-
B.E. Johnson, M. O'Halloran, and J.R. Duley
- Subjects
Ic manufacturing ,Cost structure ,business.industry ,Comparable size ,Manufacturing ,Financial analysis ,Capital cost ,Optimal deployment ,Operations management ,Business ,Variable cost ,Automotive engineering - Abstract
This paper compares the cost structure, optimal deployment policies, expected values and financial risk of 200 mm and 300 mm IC manufacturing facilities. 300 mm facilities are shown to have significantly lower capital costs than 200 mm facilities of comparable size (measured by die output), but comparable fixed recurring costs, and measurably higher variable costs. Due to the dominant role of capital costs in IC manufacturing, 300 mm fabs are significantly more valuable than comparably sized 200 mm fabs. The manufacturer's optimal policy is to outsource production until demand reaches a level at which additional in-house capacity can be fully utilized with high probability, and then to add a large, sequentially deployable 300 mm facility.
- Published
- 2003
19. Design of precision capacitors for analog applications
- Author
-
B.E. Johnson, B. El-Kareh, S.G. Franz, S. St Onge, A. Kalinoski, and A.F. Puttlitz
- Subjects
Materials science ,business.industry ,Polysilicon depletion effect ,General Engineering ,Electrical engineering ,Filter capacitor ,Capacitance ,Industrial and Manufacturing Engineering ,Electronic, Optical and Magnetic Materials ,law.invention ,Capacitor ,Film capacitor ,CMOS ,law ,Silver mica capacitor ,Optoelectronics ,Electrical and Electronic Engineering ,business ,Low voltage - Abstract
The authors describe and analyze two capacitors which are incorporated in a baseline BiCMOS technology without added process complexity. The first capacitor is formed between degenerated doped polysilicon and silicon. The second is formed between two degenerately doped polysilicon layers. In both structures, the insulator is a deposited or grown oxide. The sensitivity of the capacitor voltage coefficient to oxide thickness and surface dopant concentration is discussed theoretically and compared to measured data. The two capacitors are optimized to exhibit very low voltage coefficients. >
- Published
- 2003
20. An Assessment of Jejunostomy Tube Placement in Patients Undergoing Pancreaticoduodenectomy for Adenocarcinoma: Routine Placement is not Justified
- Author
-
Hisakazu Hoshi, James J. Mezhir, James R. Howe, Anna M. Button, Anthony R. Cyr, and B.E. Johnson
- Subjects
medicine.medical_specialty ,business.industry ,General surgery ,medicine.medical_treatment ,medicine.disease ,Pancreaticoduodenectomy ,Surgery ,Jejunostomy ,medicine ,Tube placement ,Adenocarcinoma ,In patient ,business - Published
- 2014
21. Sarcopenia Predicts Operative Complications Following Pancreatectomy for Adenocarcinoma
- Author
-
A. Asghar, Anna M. Button, B.E. Johnson, S. Joglekar, M. Rajput, S. Bell, James R. Howe, James J. Mezhir, and A. Palakodeti
- Subjects
medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Pancreatectomy ,medicine ,Adenocarcinoma ,Surgery ,medicine.disease ,business - Published
- 2014
22. Diagnostic phototesting in the United Kingdom
- Author
-
Peter M. Farr, Ian A. Magnus, D. Bilsland, James Ferguson, J.L.M. Hawk, P.G. Norris, G.M. Mruphy, Brian Diffey, B.E. Johnson, Harry Moseley, N.K. Gibbs, and A. Pierce
- Subjects
medicine.medical_specialty ,business.industry ,Family medicine ,medicine ,Phototesting ,Optometry ,Dermatology ,business - Published
- 1992
23. Photochemotherapy. A study of its efficacy in fifty patients sufFering from psoriasis and other dermatoses
- Author
-
P.W. Gould, L.A. Mackenzie, B.E. Johnson, T. Laksmipathi, and W. Frain‐Bell
- Subjects
medicine.medical_specialty ,business.industry ,Psoriasis ,Medicine ,Dermatology ,business ,medicine.disease - Published
- 2006
24. Photohaemolysis assay for drug phototoxicity complicated by 'bleaching' of released haemoglobin
- Author
-
B.E. Johnson, N.K. Gibbs, and N. J. Traynor
- Subjects
Nalidixic acid ,Chemistry ,General Medicine ,Pharmacology ,Toxicology ,Methemoglobin ,medicine ,Photosensitizer ,Hemoglobin ,Phototoxicity ,Tiaprofenic acid ,medicine.drug ,Antibacterial agent ,Heinz body - Abstract
The phototoxic potential of several non-steroidal anti-inflammatory drugs and quinolone antibiotics was assessed using the photohaemolysis assay. In this system, human erythrocytes are irradiated (UVA radiation 320-400 nm) from below in the presence of suspected photosensitizers. Photohaemolysis with ketoprofen, tiaprofenic acid or nalidixic acid was initially concentration dependent, but photohaemolysis apparently decreased at higher drug concentrations. As erythrocytes were irradiated from below any optical screening at high drug concentrations was discounted. Other phototoxic drugs can oxidize haemoglobin to methaemoglobin resulting in a decrease in absorption and an artificially lowered photohaemolysis level. However, in the present experiments, the use of Drabkin's solution overcame this effect as haemoglobin and most of its oxidized derivatives were converted into a single derivative, namely cyanmethaemoglobin. Further possibilities are that photosensitized damage to haemoglobin results in the formation of intracellular Heinz bodies and/or bleaching of released haemoglobin. The latter hypothesis was tested by irradiating free haemoglobin in the presence of drugs. The results suggested that certain phototoxic agents cause 'bleaching' of the haemoglobin and formation of a derivative that fails to react with Drabkin's solution. If only high concentrations of these drugs are used in the photohaemolysis assay, this increases the risk of false negative results. It is therefore suggested that both photohaemolysis and photosensitized 'bleaching' of haemoglobin should be investigated when using this assay for screening drug phototoxicity.
- Published
- 1996
25. British Photodermatology Group Workshop. Predictive in vitro methods for identifying photosensitizing drugs: a report
- Author
-
W. Lovell, S. Navaratnam, L. Henderson, B.E. Johnson, J.L.M. Hawk, H. du P. Menagé, S. Steer, Antony R. Young, L. Earl, Colin F. Arlett, Charlotte M. Proby, N.K. Gibbs, and James Ferguson
- Subjects
medicine.medical_specialty ,Pediatrics ,Photosensitizing Agents ,business.industry ,Internal medicine ,Toxicity Tests ,Drug Evaluation, Preclinical ,Medicine ,Humans ,Reproducibility of Results ,Dermatology ,Photosensitivity Disorders ,business - Published
- 1995
26. 986 Immunization with mutant p53-and K-ras-derived peptides in cancer patients: Immune responses and clinical outcome
- Author
-
B. Seifert, M. Kelley, Jay A. Berzofsky, J. Greenblatt, John D. Minna, B.E. Johnson, I F Ciernik, David P. Carbone, Charles S. Carter, and D. Contois
- Subjects
Cancer Research ,Immune system ,Oncology ,Immunization ,business.industry ,Mutant ,Immunology ,Medicine ,Cancer ,business ,medicine.disease - Published
- 2003
27. British photodermatology and the influence of Dr Arthur Porter
- Author
-
I. A. Magnus and B.E. Johnson
- Subjects
Gerontology ,business.industry ,Medicine ,Humans ,Dermatology ,Photosensitivity Disorders ,History, 20th Century ,Phototherapy ,business ,Classics ,United Kingdom - Published
- 1994
28. A comparison of narrow band phototherapy (TL-01) and photochemotherapy (PUVA) in the management of polymorphic light eruption
- Author
-
S.A. George, Tom Aitchison, B.E. Johnson, D.J. Bilsland, James Ferguson, and N.K. Gibbs
- Subjects
Adult ,Male ,medicine.medical_specialty ,integumentary system ,business.industry ,medicine.medical_treatment ,Follow up studies ,Dermatology ,Patient exposure ,Middle Aged ,Placebo ,Narrow band ,PUVA therapy ,medicine ,Polymorphic light eruption ,Humans ,Female ,Ultraviolet Therapy ,Photosensitivity Disorders ,Seasons ,skin and connective tissue diseases ,business ,PUVA Therapy ,Follow-Up Studies - Abstract
Twenty-five patients suffering from severe polymorphic light eruption (PLE) were randomized to either photochemotherapy (PUVA) or narrow-band phototherapy (TL-01 UVB) treatment in early spring; patients receiving UVB were given placebo tablets to achieve a matching therapy procedure. During the 4 months following treatment, patient exposure to solar UVB was monitored with polysulphone badges. PLE occurrence, severity, and restriction of outdoor activity were recorded, using weekly diary-sheets. Analysis of covariance on this data, using the logarithm of UVB exposure as the explanatory variable, showed no significant differences between the treatments. TL-01 UVB is an effective alternative to PUVA in the management of PLE.
- Published
- 1993
29. Comparative potency of broad-band and narrow-band phototherapy sources to induce edema, sunburn cells and urocanic acid photoisomerization in hairless mouse skin
- Author
-
J. Crosby, Neil K. Gibbs, B.E. Johnson, Mary Norval, Graham Lowe, and Nicola J. Traynor
- Subjects
Ratón ,Albinism ,Ultraviolet Rays ,Sunburn ,Pharmacology ,Biochemistry ,chemistry.chemical_compound ,Mice ,Immune system ,Isomerism ,Edema ,Psoriasis ,medicine ,Potency ,Animals ,Physical and Theoretical Chemistry ,Skin ,Back ,Mice, Hairless ,Chemistry ,Urocanic Acid ,Dose-Response Relationship, Radiation ,Ear ,General Medicine ,Phototherapy ,medicine.disease ,Hairless ,Urocanic acid ,Immunology ,Female ,medicine.symptom - Abstract
The Philips TL01 narrow-band (311-313 nm) fluorescent lamp provides effective phototherapy for psoriasis and atopic eczema while emitting less erythemogenic radiation than conventional broad-band (e.g. Philips TL12; 270-350 nm) sources. We studied the potency of TL01 and TL12 radiation to induce edema and sunburn cells (SBC) and to photoisomerize naturally occurring trans-urocanic acid (UCA) to cis-UCA in hairless mouse skin. Cis-UCA has immunosuppressive properties and is a putative mediator of UV-induced suppression of immune responses. For each source, there was UV dose dependence for all three responses. Within the dose ranges used, the potency ratio of TL12:TL01 radiation to induce equivalent edema and SBC was about 6:1. However, the potency ratio to induce cis-UCA was less than 2.3:1. Therefore, at a given level of edema or SBC induction, TL01 was more efficient than TL12 at UCA photoisomerization. The TL01 induction of immunomodulating cis-UCA, while causing minimal skin injury, may relate to the therapeutic efficacy of this source in skin conditions with an immunological component.
- Published
- 1993
30. Clinical and laboratory studies of the photosensitizing potential of norfloxacin, a 4-quinolone broad-spectrum antibiotic
- Author
-
James Ferguson and B.E. Johnson
- Subjects
Adult ,Male ,Nalidixic acid ,Erythema ,Adolescent ,medicine.drug_class ,Ultraviolet Rays ,Antibiotics ,Dermatology ,Pharmacology ,Hemolysis ,Nalidixic Acid ,Double-Blind Method ,Candida albicans ,medicine ,Humans ,Histidine ,Photosensitivity Disorders ,Norfloxacin ,Dose-Response Relationship, Drug ,business.industry ,DNA ,Middle Aged ,Quinolone ,Ciprofloxacin ,Phototesting ,Female ,medicine.symptom ,business ,Phototoxicity ,medicine.drug - Abstract
Cutaneous photosensitivity reactions are a consistent although uncommon feature of the fluoroquinolone group of antibiotics, which are related to nalidixic acid. Objective laboratory and clinical data are now routinely required by regulatory bodies for new drugs suspected of being photosensitizers, but no clear recommendations exist. A series of in vitro tests ranging in complexity revealed a UVA-dependent phototoxic potential for the fluoroquinolone norfloxacin similar to that for ciprofloxacin, and less than that of nalidixic acid. Controlled monochromator phototesting, designed to reveal the clinical characteristics, wavelength dependence and severity of cutaneous reactions in normal subjects showed both norfloxacin and ciprofloxacin to have a weak phototoxic potential which clears within 4 weeks of stopping the drug. UVA wavelengths (335 +/- 30 nm; 365 +/- 30 nm) appear most responsible for producing an asymptomatic erythema which is maximal at 24 h. The clinical study differs from those used previously in being blind, containing positive and negative controls, and phototesting after cessation of drug intake. The methodology has the anticipated limitation of failing to detect idiosyncratic photosensitivity responses.
- Published
- 1993
31. Action spectra for the trans to cis photoisomerisation of urocanic acid in vitro and in mouse skin
- Author
-
Markus Wolf, Neil K. Gibbs, John Crosby, Nicola J. Traynor, B.E. Johnson, and Mary Norval
- Subjects
Mice, Hairless ,Absorption spectroscopy ,Ultraviolet Rays ,Urocanic Acid ,General Medicine ,Cis-Urocanic Acid ,Chromophore ,Photochemistry ,Biochemistry ,Urocanic acid ,chemistry.chemical_compound ,Mice ,chemistry ,Isomerism ,In vivo ,Animals ,Female ,Irradiation ,Physical and Theoretical Chemistry ,Cis–trans isomerism ,Action spectrum ,Skin - Abstract
Urocanic acid (UCA) is a major UV chromophore in the upper layers of the skin where it is found predominantly as the trans isomer. UV irradiation induces photoisomerisation of trans-UCA to cis-UCA which has been shown to mimic some of the immunosuppressive properties of UV exposure. We examined the wavelength dependence for trans-UCA to cis-UCA photoisomerisation in vitro and in mouse skin in vivo over the spectral range 270-340 nm. The resulting action spectra were very similar with maximal effectiveness at 300-315 nm and equal activity at 270 nm and 325-330 nm, demonstrating that UVA-II radiation (320-340 nm) is efficient at UCA photoisomerisation. These action spectra differed markedly from the trans-UCA absorption spectrum in vitro and also the reported action spectrum for UV suppression of contact hypersensitivity in mice. These findings suggest that the relationship between cis-UCA formation in skin and UV-induced immunosuppression may be complex.
- Published
- 1993
32. In vitro phototoxicity of nifedipine: sequential induction of toxic and non-toxic photoproducts with UVA radiation
- Author
-
N. J. Traynor, James Ferguson, N.K. Gibbs, and B.E. Johnson
- Subjects
Erythrocytes ,Nifedipine ,Photochemistry ,Ultraviolet Rays ,Biophysics ,Human skin ,Absorption (skin) ,environment and public health ,Hemolysis ,Cell Line ,Cricetulus ,In vivo ,Cricetinae ,Candida albicans ,medicine ,Animals ,Humans ,Radiology, Nuclear Medicine and imaging ,MTT assay ,Irradiation ,Radiation ,Radiological and Ultrasound Technology ,Chemistry ,Dihydropyridine ,biochemical phenomena, metabolism, and nutrition ,Fibroblasts ,In vitro ,bacteria ,sense organs ,Phototoxicity ,medicine.drug - Abstract
Anecdotal reports suggest that the dihydropyridine calcium antagonist, nifedipine (NIF), may be phototoxic in human skin. We have studied NIF phototoxicity in vitro using UVA fluorescent tubes (Sylvania PUVA). NIF was phototoxic to Candida albicans and induced photohaemolysis both with NIF present during irradiation and with pre-irradiated drug. In V79 hamster fibroblasts, NIF (10 micrograms ml-1) was phototoxic MTT assay) 24 h after irradiation (0-112 kJ m-2); at 7.5 kJ m-2, about 70% of cells were damaged whilst at 37.5 kJ m-2, only about 45% of cells were damaged. A similar pattern was seen with pre-irradiated NIF. Absorption spectroscopy showed that the NIF absorption maximum (Amax approximately 340 nm) blue-shifted to 314 nm at low UVA doses (7.5 kJ m-2 or less) and red-shifted to 345 nm at higher doses (isosbestic point, 325 nm). Thin layer chromatography of irradiated NIF showed a single photoproduct (PP1; Amax approximately 314 nm) formed at 7.5 kJ m-2 or less which disappeared at higher UVA doses to give further photoproducts. PP1 was highly dark toxic to V79 cells (50% damage at about 5 micrograms ml-1) but PP1 pre-irradiated with UVA was non-toxic. Preliminary gas chromatography-mass spectroscopy studies suggest that PP1 is the nitroso derivative of NIF. These results indicate that NIF phototoxicity in vitro is partially mediated by initial formation of a toxic photoproduct (PP1) but, paradoxically, subsequent UVA irradiation may reduce phototoxicity. The NIF concentrations required to induce in vitro phototoxicity are much greater than therapeutic plasma levels. Unless there is skin accumulation of NIF or PP1, our in vitro results suggest that NIF may not be an important skin-photosensitizing agent in vivo.
- Published
- 1992
33. The DEBR rat: an animal model of human alopecia areata
- Author
-
R. F. Oliver, Colin A.B. Jahoda, B.E. Johnson, and H.J. Michie
- Subjects
Male ,medicine.medical_specialty ,Pathology ,Rodent ,Alopecia Areata ,Dermatology ,Animal model ,Internal medicine ,biology.animal ,medicine ,Animals ,Humans ,skin and connective tissue diseases ,Skin pathology ,Skin ,integumentary system ,biology ,Rats, Inbred Strains ,Alopecia areata ,medicine.disease ,Rats ,body regions ,Disease Models, Animal ,Endocrinology ,Hair loss ,Leukocytes, Mononuclear ,Female ,Epidermis ,Hair - Abstract
The Dundee experimental bald rat (DEBR) is reported as a model for human alopecia areata. Parallels with human alopecia areata were observed in relation to the gradual and patchy loss of hair and the penetration of both pelage and vibrissa follicles by mononuclear cells. In particular, the apparent disruption of the follicles within the precortical region of the epidermal component and consequent alterations of normal geometrical relationships between dermal and epidermal components relate directly to similar studies on human alopecia areata. In comparison with other previously described hypotrichotic rodent mutants, the DEBR rat exhibits a unique mechanism of hair loss which may provide important information regarding the pathomechanism of human alopecia areata.
- Published
- 1991
34. The loss of antibiotic activity of ciprofloxacin by photodegradation
- Author
-
John Ferguson, G. Phillips, and B.E. Johnson
- Subjects
Microbiology (medical) ,Light ,medicine.drug_class ,Photochemistry ,Ultraviolet Rays ,Antibiotics ,Microbial Sensitivity Tests ,medicine.disease_cause ,Ultraviolet A Radiation ,Microbiology ,Ciprofloxacin ,medicine ,Escherichia coli ,Pharmacology (medical) ,Irradiation ,Photodegradation ,Antibacterial agent ,Pharmacology ,Sunlight ,Chemistry ,Infectious Diseases ,sense organs ,Ultraviolet ,medicine.drug - Abstract
Solutions of ciprofloxacin were irradiated with different wavebands of ultraviolet and visible radiation and the antibiotic activity of the drug was determined against Escherichia coli. A wavelength dependent loss of antibiotic activity was found with maximal effect around 320 nm; no effect occurred with visible irradiation. The degree of the decrease in activity with longer wavelength ultraviolet (UVA) radiation was sufficient to indicate that human exposure to sunlight through window glass (greater than 320 nm) or UVA from tanning sunbeds may result in a significant reduction in both cutaneous and circulating levels of ciprofloxacin.
- Published
- 1990
35. Tanning with ultraviolet A sunbeds
- Author
-
A F McKinlay, Rona M. MacKie, B.E. Johnson, G. Lowe, Peter M. Farr, John L.M. Hawk, N.K. Gibbs, J Ferguson, Brian Diffey, and F R deGruijl
- Subjects
Adult ,Pathology ,medicine.medical_specialty ,Letter ,Neoplasms, Radiation-Induced ,Skin Neoplasms ,business.industry ,Ultraviolet Rays ,General Engineering ,MEDLINE ,General Medicine ,Ultraviolet a ,Dermatology ,Risk Factors ,Photosensitivity Disorder ,medicine ,General Earth and Planetary Sciences ,Humans ,Photosensitivity Disorders ,Telecommunications ,business ,Child ,Melanoma ,Research Article ,General Environmental Science - Published
- 1990
36. P79 Assessing the utility of matrix-degrading enzymes as a biomarker for disease status and therapeutic efficacy in lung cancer
- Author
-
B.E. Johnson, M.A. Moses, L. Gandhi, and A. Exarhopoulos
- Subjects
chemistry.chemical_classification ,Oncology ,Cancer Research ,medicine.medical_specialty ,Disease status ,business.industry ,Matrix (biology) ,medicine.disease ,Enzyme ,chemistry ,Internal medicine ,medicine ,Biomarker (medicine) ,Lung cancer ,business - Published
- 2007
37. 6613 POSTER Prognostic factors for radical treatment of stage III NSCLC
- Author
-
Steve Mentzer, D.J. Sugarbaker, Y.L. Colson, Elizabeth H. Baldini, Raphael Bueno, Hale B. Caglar, M. Othus, J.P. Marcoux, Aaron M. Allen, and B.E. Johnson
- Subjects
Oncology ,Radical treatment ,Cancer Research ,medicine.medical_specialty ,business.industry ,Internal medicine ,medicine ,Stage III NSCLC ,business - Published
- 2007
38. Neural tube defects in hurricane aftermath
- Author
-
Edward Cooper, Graham R. Serjeant, B.E. Johnson, E.M.W. Duff, and C.M. Danbury
- Subjects
Jamaica ,medicine.medical_specialty ,business.industry ,Incidence ,Incidence (epidemiology) ,Neural tube ,General Medicine ,Folic Acid Deficiency ,Surgery ,Disasters ,medicine.anatomical_structure ,Folic acid ,medicine ,Humans ,Neural Tube Defects ,business ,West indies - Published
- 1991
39. Phototumorigenicity of 6-methylangelicin derivatives
- Author
-
B.E. Johnson, James Ferguson, and N.K. Gibbs
- Subjects
medicine.medical_specialty ,business.industry ,Family medicine ,Medicine ,Dermatology ,business ,Mutagenicity Test - Published
- 1991
40. Furocoumarins ofHeracleum Laciniatum:isolation, phototoxicity, absorption and action spectra studies
- Author
-
G. Volden, S. Haugsbø, J. Raa, B.E. Johnson, and G. Kavli
- Subjects
Isopimpinellin ,biology ,Chemistry ,Dermatology ,Plants ,Photochemistry ,biology.organism_classification ,Bergapten ,chemistry.chemical_compound ,Furocoumarins ,Column chromatography ,Photosensitivity ,Heracleum ,5-Methoxypsoralen ,Humans ,Methoxsalen ,Immunology and Allergy ,Spectrophotometry, Ultraviolet ,Photosensitivity Disorders ,Phototoxicity ,Skin Tests ,Action spectrum - Abstract
Isolation of the furocoumarins (psoralens) bergapten, isobergapten, sphondin, isopimpinellin and pimpinellin from the Umbilliferous plant Heracleum laciniatum was carried out by column chromatography, and the structure and absorption spectra for the 5 furocoumarins isolated are described. Photoepicutaneous testing showed the strongest phototoxic effects from bergapten, marked effects from pimpinellin, weak effects from sphondin and none from the others. These in vivo findings were confirmed by the in vitro Candida test. Action spectrum studies demonstrated peak photosensitivity in the range 330-335 nm, bergapten being more than twice as phototoxic as pimpinellin.
- Published
- 1983
41. Plasma 8-methoxypsoralen concentrations in photochemotherapy of psoriasis
- Author
-
I.H. Stevenson, K.J.A. Kenicer, W. Frain‐Bell, and B.E. Johnson
- Subjects
Adult ,Male ,medicine.medical_specialty ,business.industry ,Poor responder ,medicine.medical_treatment ,Dermatology ,Middle Aged ,medicine.disease ,Kinetics ,Photochemotherapy ,Pharmacokinetics ,Psoriasis ,PUVA therapy ,medicine ,Humans ,Methoxsalen ,Female ,In patient ,business ,PUVA Therapy ,Half-Life - Abstract
A quantitative study of 8-methoxypsoralen plasma profiles in patients with psoriasis undergoing photochemotherapy shows that a poor response to the treatment may be explained in terms of abnormal pharmacokinetic behaviour. However, not all 'poor responders' exhibit an abnormal pattern and for these an alternative explanation is required.
- Published
- 1981
42. Derivations of non-separable C∗-algebras
- Author
-
Charles A. Akemann and B.E Johnson
- Subjects
Discrete mathematics ,Pure mathematics ,General problem ,Separable space ,symbols.namesake ,Tensor product ,Von Neumann algebra ,Norm (mathematics) ,Bounded function ,symbols ,Abelian group ,Analysis ,Separable hilbert space ,Mathematics - Abstract
The question of which C ∗ -algebras have only inner derivations has been considered by a number of authors for 25 years. The separable case is completely solved, so this paper deals only with the non-separable case. In particular, we show that the C ∗ -tensor product of a von Neumann algebra and an abelian C ∗ -algebra has only inner derivations. Other special types of C ∗ -algebras are shown to have only inner derivations as well such as the C ∗ -tensor product of L ( H ) (all bounded operators on separable Hilbert space) and any separable C ∗ -algebra having only inner derivations. Derivations from a smaller C ∗ -algebra into a larger one are also considered, and this concept is generalized to include derivations between C ∗ -algebras connected by a ∗ -homomorphism. Finally, we consider the general problem of a sequence of linear functionals on a C ∗ -algebra which converges to zero (in norm) when restricted to any abelian C ∗ -subalgebra. Does such a sequence converge to zero in norm? The answer is “yes” for normal functionals on L ( H ), but unknown in general.
- Published
- 1979
43. Molecular Genetic Analysis Reveals Chromosomal Deletion, Gene Amplification, and Autocrine Growth Factor Production in the Pathogenesis of Human Lung Cancer
- Author
-
J.D. Minna, J.F. Battey, B.J. Brooks, F. Cuttitta, A.F. Gazdar, B.E. Johnson, D.C. Ihde, A.-M. Lebacq-Verheyden, J. Mulshine, M.M. Nau, H.K. Oie, E.A. Sausville, E. Seifter, and M. Vinocour
- Subjects
Lung Neoplasms ,Transcription, Genetic ,Mutant ,Gene mutation ,Biology ,Biochemistry ,Cell Line ,Cytogenetics ,Proto-Oncogenes ,Gene duplication ,Genetics ,medicine ,Humans ,Allele ,Lung cancer ,Molecular Biology ,Gene ,Chromosomal Deletion ,Gene Amplification ,Cell Differentiation ,Oncogenes ,medicine.disease ,Molecular biology ,respiratory tract diseases ,Cell Transformation, Neoplastic ,Chromosome 3 ,Cancer research ,Chromosome Deletion - Abstract
These studies of lung cancer suggest that a number of molecular mechanisms may be important in the pathogenesis of lung cancer, especially SCLC. An inherited predisposition to develop SCLC may correlate with a nonfunctional, recessive allele for a gene (McKusick #18228, McKusick 1986) that maps to chromosome region 3p(14-23). Individuals at risk would be heterozygous for this allele in their germ line, carrying one copy of a normal functional gene and one mutant, recessive allele. Exposure to carcinogens, in particular cigarette smoke, can produce somatic genetic changes such as chromosomal deletion or gene mutation in the functional allele of this gene, unmasking the nonfunctional allele. Loss of this normal gene may alter the regulation of cell growth, perhaps by allowing the deregulated expression of proto-oncogenes of the myc family, or autocrine growth factors such as GRP and/or its receptor. Alternatively, loss of this gene may result in the cell returning to a less differentiated developmental state where growth regulation is less stringent. Persons with this mutant gene should be at increased risk to develop SCLC, and further RFLP analysis of the 3p region in SCLC may allow identification of specific haplotypes with increased risk of developing lung cancer. If this notion is correct, one might expect to find an increased frequency of second tumors in lung cancer patients and the presence of similar chromosomal deletions in second tumors arising in SCLC patients. In this regard, cured lung cancer patients, including those with SCLC, have a tenfold increased risk of developing a second lung cancer (Fontana 1977; Cortese et al. 1983; Johnson et al. 1986b). In fact, a chromosome 3p deletion along with other chromosomal abnormalities was identified in acute erythroleukemia cells arising in a long-term survivor of SCLC (Bradley et al. 1982), implicating this same region in the pathogenesis of both tumors. Other predictions include the correction of at least a portion of the defect by introducing a normal chromosome 3 into SCLC cells. While c-myc is expressed in many fetal and adult tissues, high-level expression of N- and L-myc is very restricted as to tissue and stage in the developing mouse, with N-myc expressed in the fetal but not adult lung, whereas the lung was the only adult tissue where L-myc expression was detected (Zimmerman et al. 1986). Could these patterns provide a clue to the differential expression of c-, N-, and L-myc found in different lung cancers (Nau et al. 1986)?(ABSTRACT TRUNCATED AT 400 WORDS)
- Published
- 1986
44. The influence of radiation on the skin and the basis of protection
- Author
-
B.E. Johnson
- Subjects
Chronic exposure ,Aging ,medicine.medical_specialty ,integumentary system ,business.industry ,Pharmaceutical Science ,Photodermatosis ,Dermatology ,medicine.disease ,Urocanic acid ,chemistry.chemical_compound ,Colloid and Surface Chemistry ,Optics ,chemistry ,Chemistry (miscellaneous) ,Photoprotection ,Drug Discovery ,medicine ,sense organs ,Sunburn ,business ,Pigmentation disorder ,Premature ageing ,Suntanning - Abstract
Synopsis This paper reviews current ideas concerning the reactions involved in sunburn, suntanning, premature ageing and carcinogenesis due to acute or chronic exposure to sunlight. The physiological mechanisms of protection involving melanin pigmentation, thickening of the epidermal horny layer and urocanic acid are briefly discussed. The importance of wavelengths from 290-315 nm (UV-B) for these reactions is emphasized as is the need to investigate further the involvement of longer wavelength (UV-A, 315-400 nm).
- Published
- 1983
45. A study of benoxaprofen-induced photosensitivity
- Author
-
P.E. McGILL, H.A. Addo, W. Frain‐Bell, K.R. Woodcock, B.E. Johnson, and James Ferguson
- Subjects
Male ,Drug ,Photolysis ,Ultraviolet Rays ,Chemistry ,media_common.quotation_subject ,Anti-Inflammatory Agents ,Benoxaprofen ,Dermatology ,Middle Aged ,Pharmacology ,Hemolysis ,Photosensitivity ,medicine ,Humans ,Female ,Drug Eruptions ,Photosensitivity Disorders ,Propionates ,Phototoxicity ,Aged ,media_common ,medicine.drug ,Action spectrum - Abstract
SUMMARY A study of the abnormal sunlight response seen in nine patients taking benoxaprofen showed that the action spectrum was between 310 and 325 nm, which is similar to the drug's absorption spectrum. In vitro studies using three separate methods indicated that benoxaprofen has a powerful phototoxic action which may be directed mainly against cellular membranes.
- Published
- 1982
46. Contact allergic sensitivity to plants and the photosensitivity dermatitis and actinic reticuloid syndrome
- Author
-
W. Frain‐Bell and B.E. Johnson
- Subjects
medicine.medical_specialty ,Photosensitivity ,In vivo ,business.industry ,medicine ,Chronic actinic dermatitis ,Dermatology ,medicine.disease ,business ,Phototoxicity ,Photosensitivity dermatitis - Abstract
SUMMARY Of sixty-nine examples of the photosensitivity dermatitis and actinic reticuloid syndrome, nine were found to be allergically sensitive to chrysanthemum oleoresin extract. Although this extract showed evidence in vitro of a phototoxic action we were unable with in vivo studies to explain the connection between the contact allergic sensitivity and the photosensitivity. The fractions responsible for the in vitro phototoxicity appear to be different from those involved in the in vivo contact allergic sensitivity. This study provides further support for the view that in the photosensitivity dermatitis and actinic reticuloid syndrome contact allergic sensitivity is of importance.
- Published
- 1979
47. Retinoid associated phototoxicity and photosensitivity
- Author
-
J. Ferguson and B.E. Johnson
- Subjects
Pharmacology ,medicine.medical_specialty ,Erythema ,business.industry ,Etretinate ,medicine.disease ,Dermatology ,Retinoids ,Photosensitivity ,Tretinoin ,medicine ,Phototesting ,Humans ,Psoriasis ,Pharmacology (medical) ,Photosensitivity Disorders ,Sunburn ,medicine.symptom ,Isotretinoin ,skin and connective tissue diseases ,Phototoxicity ,business ,medicine.drug - Abstract
Abnormal cutaneous photosensitivity is included among a number of more common side effects of tretinoin (Fig. 1; al l trans-ret inoic acid) (Pedace and Stoughton, 1971; Papa et al., 1975). The related synthetic retinoids, etretinate (Tigason) and isotretinoin (Roaccutane) (Fig. 1) may well produce a similar photosensitization. While photosensitivity is frequently listed as an adverse effect of isotretinoin, reports in the literature are contradictory. An increased susceptibility to sunburn reactions has been stated to occur in 5-12% of patients (Angel, 1983; Strauss et al., 1984) but the work of others has failed to detect this problem (Diffey et al., 1985). A single case report of clinical photosensitivity by McCormack and Turner (1983) described burning erythema of sun-exposed sites which was thought to be phototoxic in origin. Phototesting a group of subjects taking isotretinoin proved negative (Diffey et al., 1985). Etretinate has also been reported as causing sunburn reactions in 7-9% of patients (Grekin et al., 1984). Two early studies failed to produce evidence of an abnormal response to sunlight in subjects taking the drug (Ippen et al., 1978; Goerz and Orfanos, 1978) but case reports continue to appear in the literature (Collins et al., 1986).
- Published
- 1989
48. Photochemotherapy in the treatment of psoriasis
- Author
-
W. Frain‐Bell, L.A. Mackenzie, P.W. Gould, T. Lakshmipathi, and B.E. Johnson
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,Photochemistry ,business.industry ,Dermatology ,Middle Aged ,medicine.disease ,Long wavelength ,Psoriasis ,medicine ,Ultraviolet irradiation ,Humans ,Methoxsalen ,Female ,Ultraviolet Therapy ,Term effect ,Irradiation ,business - Abstract
SUMMARY This article describes the satisfactory clinical improvement obtained in the majority of a group of 72 patients with psoriasis of various types as a result of the oral and/or topical administration of 8–methoxypsoralen followed by long wavelength ultraviolet irradiation. The irradiation source used was that of conventional longwave UV fluorescent tubes mounted in a specially constructed cubicle. Until such time as the long term effect of this form of photochemotherapy on the cell has been evaluated and the most appropriate regime worked out, it would seem to be important to restrict the amount of irradiation used to that required to produce acceptable maintained clinical improvement.
- Published
- 1977
49. POSSIBLE VALUE OF FLUORESCENT LIGHTING IN THE PREVENTION OF VITAMIN D DEFICIENCY IN THE ELDERLY
- Author
-
C. Cohen, M. S. Devgun, B.E. Johnson, and C. R. Paterson
- Subjects
Aging ,medicine.medical_specialty ,Osteomalacia ,Hydroxycholecalciferols ,business.industry ,General Medicine ,Alkaline Phosphatase ,Vitamin D Deficiency ,medicine.disease ,vitamin D deficiency ,Alkaline phosphatase blood ,Endocrinology ,Internal medicine ,Vitamin D biosynthetic process ,medicine ,Ultraviolet light ,Humans ,Calcium ,Geriatrics and Gerontology ,business ,Vitamin D synthesis ,Lighting ,Aged - Abstract
Osteomalacia due to vitamin D deficiency is common in elderly women. It has been suggested that ultraviolet light may have a place in its prevention but our studies with Vita-Lite fluorescent tubes have given no support to the view that these can play a useful role in the promotion of vitamin D synthesis.
- Published
- 1980
50. The relationship between exposure to fragrance materials and persistent light reaction in the photosensitivity dermatitis with actinic reticuloid syndrome
- Author
-
James Ferguson, W. Frain‐Bell, H.A. Addo, and B.E. Johnson
- Subjects
medicine.medical_specialty ,Photolysis ,Ultraviolet Rays ,business.industry ,Syndrome ,Dermatology ,Patch Tests ,Perfume ,Skin reaction ,Persistent light reaction ,Humans ,Medicine ,Hypersensitivity, Delayed ,Photosensitivity Disorders ,business ,Phototoxicity ,Photosensitivity dermatitis - Abstract
Contact allergic sensitivity to allergens such as plants of the Compositae family is a feature of the chronic skin reaction seen in the photosensitivity dermatitis with actinic reticuloid syndrome. In fifty patients with this syndrome an increased incidence of contact allergic sensitivity to some common fragrance materials was demonstrated. Evidence is also presented, both by in vitro and in vivo studies, which indicates that a phototoxic mechanism is involved. The relevance of continued exposure to common allergens and their involvement in photosensitization mechanisms is discussed in an attempt to explain the state of 'persistent light reaction'.
- Published
- 1982
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.